[
  {
    "ts": null,
    "headline": "Two biopharma stocks to consider outside of Moderna",
    "summary": "Moderna (MRNA) shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Kritzer also weighs in on pet drug manufacturer Zoetis (ZTS). To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
    "url": "https://finnhub.io/api/news?id=a9c231607d8860c087d294ce62ced0ce463245b6502734a3d0ee71af2620ae40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748885400,
      "headline": "Two biopharma stocks to consider outside of Moderna",
      "id": 134955043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Kritzer also weighs in on pet drug manufacturer Zoetis (ZTS). To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
      "url": "https://finnhub.io/api/news?id=a9c231607d8860c087d294ce62ced0ce463245b6502734a3d0ee71af2620ae40"
    }
  },
  {
    "ts": null,
    "headline": "Top 15 High-Growth Dividend Stocks For June 2025",
    "summary": "Discover my June 2025 Top 15 high-growth dividend stocks, offering a 1.34% yield, 22.82% growth rate, and 25% undervaluation.",
    "url": "https://finnhub.io/api/news?id=ed68f4a9a8b1fc6054e82029468c3ffe75e2075c44a02f5a1258d00dc3214a7c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748858400,
      "headline": "Top 15 High-Growth Dividend Stocks For June 2025",
      "id": 134939275,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1921790815/image_1921790815.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Discover my June 2025 Top 15 high-growth dividend stocks, offering a 1.34% yield, 22.82% growth rate, and 25% undervaluation.",
      "url": "https://finnhub.io/api/news?id=ed68f4a9a8b1fc6054e82029468c3ffe75e2075c44a02f5a1258d00dc3214a7c"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis : Launches AI Masses, the New AI-Powered Cytologic Capability for Vetscan Imagyst®",
    "summary": "· AI Masses is the latest artificial intelligence powered analysis technology from Zoetis, delivering fast, accurate1,2 in-clinic screening of common lymph node and skin/subcutaneous lesions in...",
    "url": "https://finnhub.io/api/news?id=4adb78bfc69fa626adae26c2fe4e588a482faf67d2bb2360824cd176dccdaa3c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748853425,
      "headline": "Zoetis : Launches AI Masses, the New AI-Powered Cytologic Capability for Vetscan Imagyst®",
      "id": 134937169,
      "image": "",
      "related": "ZTS",
      "source": "Finnhub",
      "summary": "· AI Masses is the latest artificial intelligence powered analysis technology from Zoetis, delivering fast, accurate1,2 in-clinic screening of common lymph node and skin/subcutaneous lesions in...",
      "url": "https://finnhub.io/api/news?id=4adb78bfc69fa626adae26c2fe4e588a482faf67d2bb2360824cd176dccdaa3c"
    }
  }
]